Evidence Question
Do SGLT2 inhibitors improve systolic blood pressure?
Related to: Cardiometabolic RiskShort answer
SGLT2 inhibitors may improve systolic blood pressure.
Evidence at a glance
- Evidence strength
- Moderate Evidence
- Supporting research
- 2 studys
- Randomized trials
- 2 trials
Why do we say this?
Across 2 randomized trials, findings are mixed and showed an effect on systolic blood pressure with SGLT2 inhibitors.
Context and limitations
Some evidence reported benefits while other evidence found little or no effect.
- Only a small number of supporting studies are available.
Explore the evidence
Supporting research
2 published studys